Oncolytics Biotech® to Host Conference Call to Discuss Second Quarter Financial Results and Recent Operational Highlights
SAN DIEGO, CA and CALGARY, AB, July 27, 2022 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that it will host a conference call and webcast on Thursday, August 11, 2022, at 8:30 a.m. ET to discuss a corporate update and financial results for the second quarter of 2022.
- Oncolytics is a biotechnology company developing pelareorep, an intravenously delivered immunotherapeutic agent.
- Such forward-looking statements involve known and unknown risks and uncertainties, which could cause Oncolytics' actual results to differ materially from those in the forward-looking statements.
- It is unknown whether and how Oncolytics may be affected if the COVID-19 pandemic persists for an extended period of time.
- The Company does not undertake any obligation to update these forward-looking statements, except as required by applicable laws.